| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
53,964 |
50,716 |
$3.07M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,893 |
21,319 |
$1.76M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
6,709 |
6,640 |
$674K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,369 |
3,105 |
$279K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
674 |
674 |
$223K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
31,538 |
26,217 |
$189K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,630 |
1,628 |
$149K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,217 |
1,185 |
$122K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,808 |
3,644 |
$117K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
749 |
748 |
$104K |
| 93015 |
|
1,547 |
1,544 |
$92K |
| 99233 |
Prolong inpt eval add15 m |
1,166 |
930 |
$88K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,560 |
2,442 |
$87K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
827 |
825 |
$72K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
640 |
640 |
$71K |
| 99442 |
|
1,214 |
1,159 |
$55K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
601 |
601 |
$46K |
| 99223 |
Prolong inpt eval add15 m |
203 |
196 |
$32K |
| 93000 |
|
2,619 |
2,612 |
$32K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,968 |
1,890 |
$26K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
138 |
128 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
843 |
838 |
$12K |
| 93454 |
|
69 |
69 |
$11K |
| 90686 |
|
684 |
684 |
$11K |
| A9505 |
Thallium tl-201 thallous chloride, diagnostic, per millicurie |
230 |
230 |
$10K |
| 99441 |
|
488 |
463 |
$8K |
| 99307 |
|
221 |
88 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
162 |
162 |
$8K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
121 |
101 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
123 |
121 |
$7K |
| 99215 |
Prolong outpt/office vis |
50 |
49 |
$5K |
| 99236 |
Prolong inpt eval add15 m |
17 |
17 |
$4K |
| 93458 |
|
12 |
12 |
$3K |
| 97802 |
|
37 |
37 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
39 |
38 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
239 |
233 |
$2K |
| 99385 |
|
12 |
12 |
$2K |
| 97803 |
|
26 |
26 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
53 |
47 |
$1K |
| 93016 |
|
53 |
53 |
$1K |
| 90673 |
|
16 |
16 |
$888.97 |
| 99201 |
|
17 |
17 |
$734.27 |
| 99443 |
|
20 |
18 |
$727.84 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
15 |
15 |
$667.71 |
| 93018 |
|
51 |
51 |
$660.67 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
17 |
17 |
$418.03 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
22 |
22 |
$370.49 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
41 |
41 |
$348.36 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
26 |
$301.90 |
| 99406 |
|
24 |
24 |
$271.10 |
| 3074F |
|
19,367 |
18,665 |
$142.78 |
| 36415 |
Collection of venous blood by venipuncture |
202 |
202 |
$136.85 |
| 3078F |
|
17,529 |
16,904 |
$126.64 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$31.16 |
| 1160F |
|
4,669 |
4,449 |
$18.06 |
| G0008 |
Administration of influenza virus vaccine |
28 |
28 |
$16.00 |
| 1159F |
|
4,788 |
4,561 |
$10.21 |
| 3075F |
|
2,814 |
2,754 |
$9.84 |
| 1126F |
|
3,033 |
2,915 |
$8.08 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
31,264 |
29,985 |
$5.91 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
35,744 |
34,176 |
$5.91 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
5,371 |
5,196 |
$2.66 |
| 3044F |
|
15,295 |
14,385 |
$2.34 |
| 1170F |
|
2,349 |
2,240 |
$2.34 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
250 |
245 |
$0.45 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
75 |
75 |
$0.14 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
125 |
123 |
$0.14 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,510 |
1,433 |
$0.00 |
| 3077F |
|
2,411 |
2,337 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
7,934 |
7,505 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
3,650 |
3,532 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
689 |
643 |
$0.00 |
| G8540 |
Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter |
162 |
135 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
72 |
69 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
259 |
256 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
263 |
251 |
$0.00 |
| 4004F |
|
85 |
83 |
$0.00 |
| 1124F |
|
118 |
110 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
76 |
71 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
14 |
14 |
$0.00 |
| 2022F |
|
29 |
29 |
$0.00 |
| 4040F |
|
49 |
49 |
$0.00 |
| 3725F |
|
19 |
19 |
$0.00 |
| 3045F |
|
16 |
15 |
$0.00 |
| 4010F |
|
7,812 |
7,408 |
$0.00 |
| 1036F |
|
8,098 |
7,740 |
$0.00 |
| 1125F |
|
711 |
685 |
$0.00 |
| 3061F |
|
2,747 |
2,579 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
446 |
434 |
$0.00 |
| 3079F |
|
8,770 |
8,536 |
$0.00 |
| 3066F |
|
1,500 |
1,396 |
$0.00 |
| 1123F |
|
426 |
413 |
$0.00 |
| 3060F |
|
277 |
266 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
30 |
28 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
98 |
94 |
$0.00 |
| 3017F |
|
223 |
220 |
$0.00 |
| 3080F |
|
63 |
60 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
103 |
101 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
13 |
13 |
$0.00 |